John B. Harlow Jr. - 17 Nov 2025 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 Nov 2025
Net transactions value
$0
Form type
3
Filing time
17 Nov 2025, 16:08:43 UTC
Next filing
08 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harlow John B. Jr. Chief Commercial Officer C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 17 Nov 2025 0002095554

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.